Literature DB >> 10683382

The role of the LDL receptor in apolipoprotein B secretion.

J Twisk1, D L Gillian-Daniel, A Tebon, L Wang, P H Barrett, A D Attie.   

Abstract

Familial hypercholesterolemia is caused by mutations in the LDL receptor gene (Ldlr). Elevated plasma LDL levels result from slower LDL catabolism and a paradoxical lipoprotein overproduction. We explored the relationship between the presence of the LDL receptor and lipoprotein secretion in hepatocytes from both wild-type and LDL receptor-deficient mice. Ldlr(-/-) hepatocytes secreted apoB100 at a 3.5-fold higher rate than did wild-type hepatocytes. ApoB mRNA abundance, initial apoB synthetic rate, and abundance of the microsomal triglyceride transfer protein 97-kDa subunit did not differ between wild-type and Ldlr(-/-) cells. Pulse-chase analysis and multicompartmental modeling revealed that in wild-type hepatocytes, approximately 55% of newly synthesized apoB100 was degraded. However, in Ldlr(-/-) cells, less than 20% of apoB was degraded. In wild-type hepatocytes, approximately equal amounts of LDL receptor-dependent apoB100 degradation occured via reuptake and presecretory mechanisms. Adenovirus-mediated overexpression of the LDL receptor in Ldlr(-/-) cells resulted in degradation of approximately 90% of newly synthesized apoB100. These studies show that the LDL receptor alters the proportion of apoB that escapes co- or post-translational presecretory degradation and mediates the reuptake of newly secreted apoB-containing lipoprotein particles.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10683382      PMCID: PMC289165          DOI: 10.1172/JCI8623

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  88 in total

1.  Isolation of RNA for dot hybridization by heparin-DNase I treatment of whole cell lysate.

Authors:  Z Krawczyk; C Wu
Journal:  Anal Biochem       Date:  1987-08-15       Impact factor: 3.365

2.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

3.  Apolipoprotein B metabolism in homozygous familial hypercholesterolemia.

Authors:  R W James; B Martin; D Pometta; J C Fruchart; P Duriez; P Puchois; J P Farriaux; A Tacquet; T Demant; R J Clegg
Journal:  J Lipid Res       Date:  1989-02       Impact factor: 5.922

4.  Suppression of apolipoprotein B production during treatment of cholesteryl ester storage disease with lovastatin. Implications for regulation of apolipoprotein B synthesis.

Authors:  H N Ginsberg; N A Le; M P Short; R Ramakrishnan; R J Desnick
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

5.  Intrahepatic assembly of very low density lipoproteins. Rate of transport out of the endoplasmic reticulum determines rate of secretion.

Authors:  R A Borchardt; R A Davis
Journal:  J Biol Chem       Date:  1987-12-05       Impact factor: 5.157

6.  Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.

Authors:  T E Carew; D C Schwenke; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

7.  Human apolipoprotein B-100 heparin-binding sites.

Authors:  K H Weisgraber; S C Rall
Journal:  J Biol Chem       Date:  1987-08-15       Impact factor: 5.157

8.  Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits.

Authors:  P T Ma; G Gil; T C Südhof; D W Bilheimer; J L Goldstein; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

9.  Plasma lipoprotein distribution of apolipoprotein E in familial hypercholesterolemia.

Authors:  J C Gibson; R B Goldberg; A Rubinstein; H N Ginsberg; W V Brown; S Baker; B I Joffe; H C Seftel
Journal:  Arteriosclerosis       Date:  1987 Jul-Aug

10.  Lovastatin therapy in receptor-negative homozygous familial hypercholesterolemia: lack of effect on low-density lipoprotein concentrations or turnover.

Authors:  R Uauy; G L Vega; S M Grundy; D M Bilheimer
Journal:  J Pediatr       Date:  1988-08       Impact factor: 4.406

View more
  52 in total

Review 1.  Hepatic ABCA1 and VLDL triglyceride production.

Authors:  Mingxia Liu; Soonkyu Chung; Gregory S Shelness; John S Parks
Journal:  Biochim Biophys Acta       Date:  2011-10-06

Review 2.  Hepatic regulation of apolipoprotein B.

Authors:  Rita Kohen Avramoglu; Khosrow Adeli
Journal:  Rev Endocr Metab Disord       Date:  2004-12       Impact factor: 6.514

Review 3.  Studying apolipoprotein turnover with stable isotope tracers: correct analysis is by modeling enrichments.

Authors:  Rajasekhar Ramakrishnan
Journal:  J Lipid Res       Date:  2006-09-01       Impact factor: 5.922

4.  Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia.

Authors:  Christopher Jones; Rita Garuti; Peter Michaely; Wei-Ping Li; Nobuyo Maeda; Jonathan C Cohen; Joachim Herz; Helen H Hobbs
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

5.  Familial hypercholesterolaemia.

Authors:  A David Marais
Journal:  Clin Biochem Rev       Date:  2004-02

6.  High density lipoprotein metabolism in low density lipoprotein receptor-deficient mice.

Authors:  Franz Rinninger; Markus Heine; Roshni Singaraja; Michael Hayden; May Brundert; Rajasekhar Ramakrishnan; Joerg Heeren
Journal:  J Lipid Res       Date:  2014-06-22       Impact factor: 5.922

7.  Lipid profile and Atherogenic Indices in Nigerians Occupationally Exposed to e-waste: A Cardiovascular Risk Assessment Study.

Authors:  Osaretin Godwin Igharo; Yinka Akinfenwa; Alphonsus R Isara; Festus Aigbokheo Idomeh; Nnenna L Nwobi; John I Anetor; Oladele Osibanjo
Journal:  Maedica (Bucur)       Date:  2020-06

8.  Cholesterol synthesis inhibition elicits an integrated molecular response in human livers including decreased ACAT2.

Authors:  Paolo Parini; Ulf Gustafsson; Matt A Davis; Lilian Larsson; Curt Einarsson; Martha Wilson; Mats Rudling; Hiroshi Tomoda; Satoshi Omura; Staffan Sahlin; Bo Angelin; Lawrence L Rudel; Mats Eriksson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-03-13       Impact factor: 8.311

9.  Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion.

Authors:  Meenakshi Sundaram; Zemin Yao
Journal:  Nutr Metab (Lond)       Date:  2010-04-27       Impact factor: 4.169

10.  Insulin acutely inhibits intestinal lipoprotein secretion in humans in part by suppressing plasma free fatty acids.

Authors:  Mirjana Pavlic; Changting Xiao; Linda Szeto; Bruce W Patterson; Gary F Lewis
Journal:  Diabetes       Date:  2009-12-22       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.